| Literature DB >> 35635053 |
Yuanyuan Long1, Chenxing Li2, Baoyu Zhu3.
Abstract
Oral squamous cell carcinoma (OSCC) is a common cancer with high recurrence, metastasis rates and poor prognosis. Circular RNAs (circRNAs) take part in regulating OSCC. Herein, we examined the role of circ_0008068 in OSCC. The circ_0008068, Katanin p60 ATPase-containing subunit A-like 1 (KATNAL1) mRNA, microRNA-153-3p (miR-153-3p) and acylgycerol kinase (AGK) contents were indicated by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. Moreover, in vitro and in vivo assays were conducted to scrutinize the effects of circ_0008068 on OSCC. Additionally, the contact between miR-153-3p and circ_0008068 or AGK was assessed by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Thereafter, we found that the appearance of circ_0008068 and AGK was increased, and miR-153-3p content was diminished in OSCC. Circ_0008068 lack subdued cell proliferation, migration, invasion, tube formation and glycolysis metabolism, but stimulated cell apoptosis in OSCC. In addition, circ_0008068 bound to miR-153-3p to modulate the expression of its target AGK. Besides, miR-153-3p was validated to act as a tumor suppressor in OSCC tumorigenesis by suppressing AGK. Additionally, circ_0008068 knockdown also attenuated tumor growth in nude mice. In all, circ_0008068 expedited the growth of OSCC by miR-153-3p/AGK axis.Abbreviations: OSCC: Oral squamous cell carcinoma; AGK: Acylgycerol kinase; CircRNA: Circular RNA; KATNAL1: Katanin p60 ATPase-containing subunit A-like 1; qRT-PCR: Quantitative real-time polymerase chain reaction; miRNAs/miRs: MicroRNAs; RIP: RNA immunoprecipitation; 3'UTR3': -untranslated region; HK2: Hexokinase 2; LDHA Lactate dehydrogenase A; IHC: Immunohistochemistry; CCK8: Cell counting kit-8; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.Entities:
Keywords: AGK; Oral squamous cell carcinoma; circ_0008068; miR-153-3p
Mesh:
Substances:
Year: 2022 PMID: 35635053 PMCID: PMC9275858 DOI: 10.1080/21655979.2022.2074106
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 6.832
Associations between circ_0008068 expression and clinical features in OSCC patients (n = 37)
| | | Circ_0008068 expression (n) | | |
|---|---|---|---|---|
| Clinical feature | Cases (n) | High [ | Low [ | |
| 0.8859 | ||||
| ≤60 years | 21 | 11 | 10 | |
| >60 years | 16 | 8 | 8 | |
| 0.2536 | ||||
| Female | 20 | 12 | 8 | |
| Male | 17 | 7 | 10 | |
| 0.0263* | ||||
| Yes | 25 | 16 | 9 | |
| NO | 12 | 3 | 9 | |
| 0.0035* | ||||
| I–II | 12 | 2 | 10 | |
| III | 25 | 17 | 8 | |
| 0.0016* | ||||
| ≤3 | 15 | 3 | 12 | |
| >3 | 22 | 16 | 6 | |
| 0.0201* | ||||
| Grade 1 | 15 | 4 | 11 | |
| Grade 2 + 3 | 22 | 15 | 7 | |
aThe median of relative circ_0008068 expression level is 2.14 so the number of high circ_0008068 expression is 19 (≥2.14)
Primers for PCR
| Name | Primers for PCR (5’-3’) | |
|---|---|---|
| circ_0008068 | Forward | TTCCCGTGGGACATTGATGA |
| Reverse | AGTCGTAATTTCCAAGAAGGGCA | |
| AGK | Forward | GCTTGACCCGACAAGCAAAG |
| Reverse | ACGCAGCTTCACTATGTTCTCT | |
| miR-153-3p | Forward | ACACTCCAGCTGGGTTGCATAGTCACAAA |
| Reverse | CAGTGCGTGTCGTGGAGT | |
| miR-140-5p | Forward | GCCGAGCAGTGGTTTTACCC |
| Reverse | CAGTGCGTGTCGTGGAGT | |
| miR-182-5p | Forward | GCCGAGTTTGGCAATGGTAGAA |
| Reverse | CAGTGCGTGTCGTGGAGT | |
| miR-197 | Forward | GCCGAGTTCACCACCTTCTCCA |
| Reverse | CAGTGCGTGTCGTGGAGT | |
| miR-637 | Forward | GCCGAGACTGGGGGCTTTCGGG |
| Reverse | CAGTGCGTGTCGTGGAGT | |
| miR-7 | Forward | GCCGAGCAACAAATCACAGTCT |
| Reverse | CAGTGCGTGTCGTGGAGT | |
| GAPDH | Forward | TCCCATCACCATCTTCCAGG |
| Reverse | GATGACCCTTTTGGCTCCC | |
| U6 | Forward | CTCGCTTCGGCAGCACATATACT |
| Reverse | ACGCTTCACGAATTTGCGTGTC | |
| KATNAL1 | Forward | AAGGGAAGTGGAGGTCTCTGA |
| Reverse | GAATCTGCTGCATCACCCCC |
Figure 1.Circ_0008068 appearance was enhanced in OSCC.
Figure 2.Circ_0008068 lack subdued OSCC tumorigenesis.
Figure 3.Circ_0008068 acted as a sponge for miR-153-3p.
Figure 4.Circ_0008068 assisted OSCC via miR-153-3p.
Figure 5.MiR-153-3p targeted AGK in CAL27 and SCC25 cells.
Figure 6.MiR-153-3p suppressed OSCC progression via AGK.
Figure 7.The appearance of AGK in OSCC cells.
Figure 8.Circ_0008068 lack delimited tumor growth by suppressing AGK via miR-153-3p.